Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Nvidia Shares Plunge from Record High Amid US-China Trade Tensions

Robert Sasse by Robert Sasse
October 11, 2025
in AI & Quantum Computing, Nasdaq, Semiconductors, Tech & Software
0
Nvidia Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Friday’s trading session delivered a severe blow to Nvidia investors as the artificial intelligence chipmaker’s stock experienced a dramatic sell-off, plummeting nearly 5% despite having reached a fresh all-time high earlier in the day. The sudden reversal was triggered by escalating trade tensions between the United States and China, raising concerns about whether geopolitical factors might undermine the AI sector’s growth trajectory.

Market Turmoil Erases Early Gains

The trading day commenced on an optimistic note for Nvidia shareholders as the stock climbed to unprecedented levels. This initial enthusiasm quickly evaporated when the share price collapsed by 4.9% to settle at approximately $183.16, after touching an intraday low of $182.05. Trading activity surged dramatically throughout the session, with 260.2 million shares changing hands—significantly exceeding the stock’s average volume.

The sharp decline was part of a broader technology sector retreat, with the Nasdaq Composite index falling 3.6% and other major benchmarks also registering substantial losses. Market analysts attributed the widespread selling pressure to renewed threats from Washington regarding potential “massive tariff increases on Chinese goods.”

Should investors sell immediately? Or is it worth buying Nvidia?

Semiconductor Sector Faces Geopolitical Headwinds

Nvidia finds itself in a particularly vulnerable position as trade tensions intensify. The chip manufacturer occupies a central role in the technological competition between the world’s two largest economies, facing multiple challenges:

  • Proposed legislation in the U.S. Senate aims to restrict exports of AI chips to China
  • Chinese authorities have already begun tightening customs inspections of Nvidia’s AI processors
  • Industry competitors including AMD witnessed similar substantial declines

The Chinese market represents a crucial revenue source for Nvidia’s artificial intelligence technology. The potential implementation of stricter trade barriers could significantly impact the company’s sales projections, with investors already factoring in potential supply chain disruptions and limited market access that might directly affect future profitability.

Ad

Nvidia Stock: Buy or Sell?! New Nvidia Analysis from February 7 delivers the answer:

The latest Nvidia figures speak for themselves: Urgent action needed for Nvidia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nvidia: Buy or sell? Read more here...

Tags: Nvidia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Conduent Stock
Cyber Security

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

February 7, 2026
Allscripts Healthcare Stock
Analysis

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Next Post
Microsoft Stock

Microsoft's AI Breakthrough Meets Market Reality

Unitedhealth Stock

UnitedHealth Faces Market Test Amid Conflicting Signals

Advanced Micro Devices Stock

AMD's OpenAI Partnership Ignites Stock Surge and Strategic Shift

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com